Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2006 Jul 27;20(4):160–163. doi: 10.1002/jcla.20125

22q11 microdeletion studies in the heart tissue of an abortus involving a familial form of congenital heart disease

ZM Patel 1,, HM Gawde 1, MI Khatkhatay 1
PMCID: PMC6807520  PMID: 16874809

Abstract

Microdeletion of chromosome 22 is responsible for DiGeorge syndrome, Velo Cardio Facial syndrome, and conotruncal defects. Here, we report on a case of microdeletion 22q11.2 in the heart tissue of a miscarried fetus in a family whose two children had died due to complex congenital heart disease. Fluorescence in situ hybridization (FISH) analysis in the couple revealed that the mother was mosaic for microdeletion of chromosome 22q11.2 in 10% of her peripheral lymphocytes. Prenatal diagnosis was offered to her in her third pregnancy. On routine ultrasonography at 10 weeks, the overall view of the heart was normal. However, before any further tests could be performed, she miscarried at 16 weeks. FISH studies on the heart tissue of the abortus revealed 22q11.2 microdeletion with two different cell lines. This suggests the importance of performing FISH studies when there is a history of congenital heart disease, even though ultrasonography shows a normal view of the heart. J. Clin. Lab. Anal. 20:160–163, 2006. © 2006 Wiley‐Liss, Inc.

Keywords: CHD, FISH, familial, chromosome 22q11.2

REFERENCES

  • 1. Wilson DF, Cross IE, Wren C, Scambler PJ, Burn J, Goodship J. Minimum prevalence of Chromosome 22q11 deletion. Am J Hum Genet 1994;55:A169. [Google Scholar]
  • 2. Tezenas du Montal S, Mendizabal H, Ayme S, Levy A, Philip N. Prevalence of 22q11 microdeletion. J Med Genet 1996;33:710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Morrow B, Goldberg R, Carlson C, et al. Molecular definition of the deletion in velocardiofacial syndrome. Am J Hum Genet 1995;56:1391–1403. [PMC free article] [PubMed] [Google Scholar]
  • 4. Lee W, Han K, Harris CP, Meisner LS. Detection of aneuploidy and possible deletion in paraffin embedded rhabdomyosarcoma with FISH. Cancer Genet Cytogenet 1993;68:99–103. [DOI] [PubMed] [Google Scholar]
  • 5. Yang P, Hirose T, Hasegawa T, Hizawa K, Sano T. Dual colour fluorescence in situ hybridization analysis of synovial sarcoma. J Pathol 1998;184:7–13. [DOI] [PubMed] [Google Scholar]
  • 6. Van Hemel Jo, Schaap C, Van Opstal D, Mulder MP, Niermeijer MF, Meijers JHC. Recurrence of DiGeorge syndrome prenatal detection by FISH of molecular 22q11 deletion. J Med Genet 1995;32:657–658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Seaver LH, Pierpont JW, Erickson RP, Donnesten RL, Casoidy SB. Pulmonary atresia associated with maternal 22q11 deletion. Possible parent of origin effect in the conotruncal anomaly face. J Med Genet 1994;31:830–834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Raymond FL, Simpson JM, Mackie CM, Shalland GK. Prenatal diagnosis of 22q11 deletion a series of five cases with congenital heart defects. J Med Genet 1997;34:679–682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Rigel M, Baumer A, Wisser J, Acherman J, Schinzel A. Prenatal diagnosis of mosaicism for a del (22q13). Prenat Diagn 2000;20:76–79. [DOI] [PubMed] [Google Scholar]
  • 10. Driscoll DA, Budarf ML, Emanuel BS. Antenatal diagnosis of DiGeorge syndrome. Lancet 1991;338:1390–1391. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES